IRIS
MANZIA, TOMMASO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.739
EU - Europa 1.231
AS - Asia 549
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
AF - Africa 4
Totale 20.554
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.729
CN - Cina 342
IE - Irlanda 250
DE - Germania 224
IT - Italia 215
UA - Ucraina 195
GB - Regno Unito 116
KR - Corea 99
SE - Svezia 51
FI - Finlandia 47
FR - Francia 38
RU - Federazione Russa 37
IN - India 24
BE - Belgio 17
VN - Vietnam 17
SG - Singapore 12
BR - Brasile 11
TR - Turchia 11
HK - Hong Kong 10
CA - Canada 9
JP - Giappone 9
EU - Europa 7
GR - Grecia 7
AU - Australia 6
ES - Italia 6
NL - Olanda 6
CH - Svizzera 4
EG - Egitto 4
TM - Turkmenistan 4
CO - Colombia 3
HR - Croazia 3
IL - Israele 3
IQ - Iraq 3
PL - Polonia 3
PT - Portogallo 3
AT - Austria 2
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
KH - Cambogia 2
MY - Malesia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MV - Maldive 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
TW - Taiwan 1
Totale 20.554
Salva come PNG Salva come JPEG
Città #
Wilmington 5.354
Houston 4.909
Woodbridge 4.298
Fairfield 796
Ann Arbor 472
Chandler 466
Ashburn 339
Seattle 306
Cambridge 287
Dublin 239
Medford 184
Jacksonville 168
Beijing 124
New York 118
Zhengzhou 101
Lawrence 86
Rome 75
Dearborn 73
San Diego 50
Creede 45
Menlo Park 34
Mülheim 28
Palo Alto 24
London 22
Santa Clara 21
Shanghai 21
Nanjing 19
Mountain View 18
Redwood City 17
Brussels 16
Milan 16
Norwalk 16
Dong Ket 14
Boardman 13
Seoul 13
Engelhard 12
Hefei 12
Los Angeles 12
Hounslow 9
Toronto 9
Islington 8
Saint Petersburg 8
University Park 8
Aydin 7
Guangzhou 7
Helsinki 7
Kunming 7
Nanchang 7
Nürnberg 7
San Mateo 7
Verona 7
Civita Castellana 6
Colorado Springs 6
Falls Church 6
Hong Kong 6
New Bedfont 6
Pune 6
São Paulo 6
Turin 6
Chicago 5
Miami 5
Shenyang 5
Washington 5
Athens 4
Chiswick 4
Amsterdam 3
Delhi 3
Detroit 3
Eschweiler 3
Esslingen am Neckar 3
Gdynia 3
Hebei 3
Jinan 3
Kilburn 3
Lappeenranta 3
Phoenix 3
San Francisco 3
Sydney 3
Thessaloniki 3
Xian 3
Yinchuan 3
Zagreb 3
Asaka 2
Augusta 2
Basra 2
Bhubaneswar 2
Budapest 2
Chateaugiron 2
Chennai 2
Cuttack 2
Enterprise 2
Hangzhou 2
Hanoi 2
Indiana 2
Istanbul 2
Kolkata 2
Kuala Lumpur 2
Kwai Chung 2
Madrid 2
Mapo-gu 2
Totale 19.079
Salva come PNG Salva come JPEG
Nome #
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 437
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 435
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 433
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 424
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 422
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 418
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 417
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 416
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 413
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 413
Marginal donors in liver transplantation. 410
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 402
Management of spermatic cord liposarcoma in renal transplant recipients: case report 394
Liver abscess caused by foreign body ingestion 394
Use of mycophenolate mofetil in liver transplantation: a literature review. 392
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 391
596 386
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 386
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 382
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 379
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 374
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 374
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 372
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 367
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 366
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 365
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 365
Liver transplantation for the treatment of nodular regenerative hyperplasia 364
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 356
Immunosuppression-Free Liver Transplantation 354
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 351
Prospect for kidney bioengineering: Shortcomings of the status quo 344
Myopericytoma of the Liver Hilus: A Case Report 337
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 330
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 320
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 314
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 309
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 306
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 299
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 276
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 274
An unusual duodenal polyp causing anemia in a liver-transplanted patient 264
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 250
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 249
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 247
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 241
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 226
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 224
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 208
Rare malignant glomus tumor of the stomach with liver metastases 203
Pandora’s Box: Unpredictable Evolution of a 20-Year History of a Bariatric Patient—Report of Small Bowel Migrated Gastric Band after Redo Banded Gastric Bypass 201
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 170
Liver transplantation for hepatocellular carcinoma: Where do we stand? 156
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 146
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 145
Platelets and hepatocellular cancer: Bridging the bench to the clinics 143
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 142
Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report 140
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 136
Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome 130
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 130
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 126
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 118
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 116
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 116
Abdominal organ bioengineering: current status and future perspectives 115
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 106
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 104
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 74
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 72
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 71
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 55
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 46
Moving forward in the treatment of cholangiocarcinoma 34
High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up 34
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 33
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 32
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 32
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 32
Chronic rejection after liver transplantation: Opening the Pandora's box 29
Temporal trends of waitlistings for liver transplantation in Italy: the ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study 28
High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up 23
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 23
Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation 23
Towards tolerance in liver transplantation 22
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 21
Global management of a common, underrated surgical task during the COVID-19 pandemic: Gallstone disease - An international survery 19
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 18
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 18
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 17
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 17
Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation 16
The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy 16
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 15
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 15
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation 15
Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis 15
Liver transplantation from active COVID-19 donors: a lifesaving opportunity worth grasping? 14
The management of immunosuppression in kidney transplant recipients with COVID-19 disease: an update and systematic review of the literature 14
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation 13
Totale 20.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.107 0 0 0 0 0 0 0 0 0 0 555 552
2019/20205.975 494 439 363 519 430 533 552 491 630 575 437 512
2020/20214.039 472 487 459 484 391 458 473 454 78 125 95 63
2021/2022933 54 90 16 32 24 95 61 33 123 117 54 234
2022/20231.436 141 123 20 153 116 261 111 261 109 12 94 35
2023/2024583 80 38 81 17 100 163 33 13 20 38 0 0
Totale 21.034